| 1 |
31836451 | Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer. | 2020 Mar |
1 |
| 2 |
31958486 | Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma. | 2020 Apr 28 |
1 |
| 3 |
31999555 | Bisindolemethane derivatives as highly potent anticancer agents: Synthesis, medicinal activity evaluation, cell-based compound discovery, and computational target predictions. | 2020 Jan |
1 |
| 4 |
31725895 | The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN. | 2019 Nov 26 |
1 |